observational study

3 · 20 / page

Ask MedXY AI

Latest news

Tag

Diabetes & EndocrinologySGLT2 inhibitorslung cancer

SGLT2 Inhibitors Linked to Lower Lung Cancer Risk in Patients With COPD and Type 2 Diabetes

By MedXY|Jul 29, 2026

A nationwide cohort study found that SGLT2 inhibitor initiation was associated with a 27% lower risk of incident lung cancer in patients with COPD and type 2 diabetes compared with sulfonylureas.

Survival Without Glucocorticoid Treatment in Classic and Non-Classic 21-Hydroxylase Deficiency: A Retrospective Cohort Study

Diabetes & Endocrinologycongenital adrenal hyperplasia21-hydroxylase deficiency

observational study

Latest news

SGLT2 Inhibitors Linked to Lower Lung Cancer Risk in Patients With COPD and Type 2 Diabetes

Survival Without Glucocorticoid Treatment in Classic and Non-Classic 21-Hydroxylase Deficiency: A Retrospective Cohort Study

Baseline SGLT2 Inhibitor Use Associated with Lower Risk of Sepsis-Induced Cardiomyopathy and Improved Outcomes in Type 2 Diabetes: Insights from a Large Propensity-Matched Cohort